Signum Surgical is a pioneering brand that is dedicated to developing innovative solutions for patients suffering from colorectal diseases, with a particular focus on anal fistula. Anal fistula is a distressing condition that affects countless individuals worldwide. It is characterized by an abnormal tunnel between the rectum and the skin of the buttocks caused by an infected or blocked anal gland.

Unfortunately, current treatment options for anal fistula often yield unsatisfactory outcomes, ranging from slow and inadequate healing to a high risk of fecal incontinence and the need for repeat surgeries. Consequently, patients experience a poor quality of life, enduring pain, suffering, and discharge from the tract and related abscesses. Signum Surgical's groundbreaking BioHealx™ technology offers new hope for patients with anal fistula.

This novel approach represents a minimally invasive solution that aims to provide effective and permanent cure. By addressing the limitations of existing treatments, Signum Surgical strives to improve patients' outcomes and enhance their overall well-being. Founded in 2016 by Eoin Bambury and Moshe Zilversmit, Signum Surgical is headquartered in Galway, Ireland.

Bambury and Zilversmit bring decades of combined experience in the medical device industry, and their visionary leadership drives the brand's commitment to pushing the boundaries of medical innovation. With a team of renowned experts and board members who possess extensive backgrounds in medical device development, intellectual property, and bioabsorbable materials, Signum Surgical is well-equipped to revolutionize the treatment of colorectal diseases. Stay updated with the latest news and developments from Signum Surgical as they continue to make significant strides in the field.

To join their team or for general inquiries, email them at info@signumsurgical. com. Signum Surgical - Developing Minimally Invasive Technologies to Treat Colorectal Diseases